Next Article in Journal
Immunogenicity and Protective Activity of Pigeon Circovirus Recombinant Capsid Protein Virus-Like Particles (PiCV rCap-VLPs) in Pigeons (Columba livia) Experimentally Infected with PiCV
Next Article in Special Issue
Advancements in mRNA Encoded Antibodies for Passive Immunotherapy
Previous Article in Journal
Radiation-Inactivated Acinetobacter baumannii Vaccine Candidates
Previous Article in Special Issue
Development of mRNA Vaccines: Scientific and Regulatory Issues
Review

An Update on Self-Amplifying mRNA Vaccine Development

1
Michael Smith Laboratories, School of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T 1Z4, Canada
2
Precision NanoSystems Inc., Vancouver, BC V6P 6T7, Canada
*
Author to whom correspondence should be addressed.
Academic Editor: Norbert Pardi
Vaccines 2021, 9(2), 97; https://doi.org/10.3390/vaccines9020097
Received: 16 December 2020 / Revised: 21 January 2021 / Accepted: 23 January 2021 / Published: 28 January 2021
(This article belongs to the Special Issue The Past, Present, and Future of mRNA Vaccines)
This review will explore the four major pillars required for design and development of an saRNA vaccine: Antigen design, vector design, non-viral delivery systems, and manufacturing (both saRNA and lipid nanoparticles (LNP)). We report on the major innovations, preclinical and clinical data reported in the last five years and will discuss future prospects. View Full-Text
Keywords: RNA; self-amplifying RNA; replicon; vaccine; drug delivery RNA; self-amplifying RNA; replicon; vaccine; drug delivery
Show Figures

Figure 1

MDPI and ACS Style

Blakney, A.K.; Ip, S.; Geall, A.J. An Update on Self-Amplifying mRNA Vaccine Development. Vaccines 2021, 9, 97. https://doi.org/10.3390/vaccines9020097

AMA Style

Blakney AK, Ip S, Geall AJ. An Update on Self-Amplifying mRNA Vaccine Development. Vaccines. 2021; 9(2):97. https://doi.org/10.3390/vaccines9020097

Chicago/Turabian Style

Blakney, Anna K., Shell Ip, and Andrew J. Geall 2021. "An Update on Self-Amplifying mRNA Vaccine Development" Vaccines 9, no. 2: 97. https://doi.org/10.3390/vaccines9020097

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop